What is more, several target genes were identified for miR-181c-5p, including SMAD7 (a negative regulator of TGF-β signaling) engaged in Th17 differentiation, being a major driver of CNS autoimmunity in MS [121]. The gene discussed is TGFB1; the disease is myeloid sarcoma.